The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics
ثبت نشده
چکیده
Ashton, J. C., I. Appleton, et al. (2004). "Cannabinoid CB1 receptor protein expression in the rat choroid plexus: a possible involvement of cannabinoids in the regulation of cerebrospinal fluid." Neurosci Lett 364(1): 40-2. Cannabinoid CB1 receptors in the brain are expressed on axon terminals presynaptic to neurons that express fatty acid amide hydrolase (FAAH). Postsynaptic FAAH catabolizes endocannabinoids which act as short-range transmitters. It has been previously shown that FAAH is also expressed in the epithelial cells of the choroid plexus. Using immunohistochemisty, we found that CB1 receptor protein is also expressed in choroid plexus epithelia. This is consistent with the hypothesis that FAAH in choroid plexus epithelial cells catabolizes endocannabinoids close to their site of action. Cannabinoids may then act directly on choroid plexus cells, and thereby contribute to the regulation of the composition of the CSF.
منابع مشابه
The Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics
Here is the latest summary of research abstracts. A reminder that the 2005 Symposium on the Cannabinoids to be held June 24th 27th, 2005 at the Hilton Clearwater Beach Resort in Clearwater, Florida USA; registration details are available at http://CannabinoidSociety.org/. In addition a workshop entitled “Cannabinoids: developing clinically useful analgesics” has been announced at the Internatio...
متن کاملThe Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics
Chen, R. Z., R. R. Huang, et al. (2004). "Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice." Brain Res 999(2): 227-30. Oral administration of the opioid antagonist nalmefene alone (up to 20 mg/kg) failed to show a significant effect on acute food intake in mice. However, combined oral dosing of nalmefene and subthreshold doses of AM...
متن کاملThe Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics
Ashton, J. C., I. Appleton, et al. (2004). "Immunohistochemical Localization of Cerebrovascular Cannabinoid CB1 Receptor Protein." J Cardiovasc Pharmacol 44(5): 517-9. Cannabinoids are powerful hypotensives and vasodilators. However, their mode of action is controversial. This study is the first to investigate the distribution of vascular CB1 receptor protein expression in situ. We used double-...
متن کاملThe Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics
Black, S. C. (2004). "Cannabinoid receptor antagonists and obesity." Curr Opin Investig Drugs 5(4): 389-94. The cannabinoid-1 (CB1) receptor plays a role in the regulation of appetitive behavior. Exogenously administered cannabinoid receptor agonists stimulate food consumption in animals and humans. Endogenous cannabinoid receptor agonists are present in the brain, and the brain level of these ...
متن کاملThe Canadian Consortium for the Investigation of Cannabinoids in Human Therapeutics
Ahmad, S. and A. Dray (2004). "Novel G protein-coupled receptors as pain targets." Curr Opin Investig Drugs 5(1): 67-70. G protein-coupled receptors (GPCRs) and their ligands play a number of important roles in the modulation of acute and chronic pain. Indeed, opioid and cannabinoid ligands are of established therapeutic value for pain management, and further exploitation of the specific GPCR s...
متن کامل